The Republican health care plan, which would roll back the Affordable Care Act and reduce or terminate health coverage for millions of Americans, will deepen the nation’s opioid crisis, addiction experts tell the Los Angeles Times.
“It would essentially write off a generation,” said Dr. Shawn Ryan, President of BrightView Health, a network of drug treatment clinics in Cincinnati. “It would be catastrophic.”
Full story of Republican health care plan and opioid crisis at drugfree.org
Adult marijuana use rose significantly in states that passed loosely regulated medical marijuana laws (MMLs) according to a new study by Columbia University’s Mailman School of Public Health and Columbia University Medical Center. Highest increases were reported among adults ages 26 and over. Little change was found in past-month marijuana use among adolescents or young adults between the ages 18 and 25. The findings are published online in the journal Addiction.
Adults 26 years of age and older living in states with less regulated medical marijuana programs increased past-month marijuana use from 4 percent to 6.59 percent after the laws were enacted. No significant change was found in the prevalence of cannabis use disorder among adolescents or adults after states enacted medical marijuana laws, regardless whether programs were highly regulated or “loose.”
Using data from the National Survey of Drug Use and Health from 2004-2013 the researchers analyzed trends over time with particular emphasis on age groups. This included obtaining prevalences of marijuana use outcomes at the state level by year and whether the enacted laws included a highly regulated (“medicalized”) or less regulated (“non-medical”) program. Participants were classified as having marijuana abuse or dependence based on DSM-IV criteria.
Full story of marijuana use rates depending on location at Science Daily
Only one in four young adults and teens with opioid use disorder (OUD) are receiving potentially life-saving medications for addiction treatment, according to a new Boston Medical Center (BMC) study published online in JAMA Pediatrics.
Buprenorphine and naltrexone are medications used to treat OUD that help prevent relapse and overdose when used appropriately. In late 2016, the American Academy of Pediatrics recommended, for the first time, that providers offer medication treatment to adolescents with OUD.
Prior studies have shown that among all adults in treatment for opioids, one-third started using opioids before age 18, and two-thirds started before age 25. Unlike methadone, buprenorphine and naltrexone can be offered in the primary care setting. However, few teens receive medication due, in part, to a widespread shortage of physicians who have received a waiver certification required to prescribe buprenorphine. And, as researchers note, of all of the physicians who are certified in the United States, only one-percent are pediatricians.
Full story of treating young people with opioid use disorder at drugfree.org
The regulatory approaches to marijuana and tobacco in the United States are on decidedly different paths and, according to researchers from the U.S. and Australia, neither side appears interested in learning from the other.
“The two policy communities have shown very little interest in each other’s policy debates,” Wayne Hall and Lynn Kozlowski write in a new paper published in the journal Addiction.
Hall, the lead author, is a professor at the Centre for Youth Substance Abuse Research at the University of Queensland, Australia, and is an expert on marijuana and other drug use issues. Kozlowski is professor of community health and health behavior in the University at Buffalo’s School of Public Health and Health Professions and an expert on tobacco use and control.
Full story of marijuana and tobacco policy camps at Science Daily
Two senators on the Judiciary Committee are preparing a bill that would create tough new penalties for people caught with synthetic opioids, NPR reports.
Republican Senator Chuck Grassley of Iowa and Democratic Senator Dianne Feinstein of California, who have supported reducing some drug sentences, are preparing the new bill. Grassley is the Chair of the Senate Judiciary Committee. Feinstein is the committee’s ranking member.
Full story of new penalties for synthetic opioids at drugfree.org